T-cell lymphomas, version 2.2022: NCCN Clinical Practice Guidelines in Oncology Guidelines

  

Authors:	Horwitz, S. M.; Ansell, S.; Ai, W. Z.; Barnes, J.; Barta, S. K.; Brammer, J.; Clemens, M. W.; Dogan, A.; Foss, F.; Ghione, P.; Goodman, A. M.; Guitart, J.; Halwani, A.; Haverkos, B. M.; Hoppe, R. T.; Jacobsen, E.; Jagadeesh, D.; Jones, A.; Kallam, A.; Kim, Y. H.; Kumar, K.; Mehta-Shah, N.; Olsen, E. A.; Rajguru, S. A.; Rozati, S.; Said, J.; Shaver, A.; Shea, L.; Shinohara, M. M.; Sokol, L.; Torres-Cabala, C.; Wilcox, R.; Wu, P.; Zain, J.; Dwyer, M.; Sundar, H.
Title:	T-cell lymphomas, version 2.2022: NCCN Clinical Practice Guidelines in Oncology
Abstract:	Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma, anaplastic lymphoma kinase-negative, and enteropathy-associated T-cell lymphoma. This discussion section focuses on the diagnosis and treatment of PTCLs as outlined in the NCCN Guidelines for T-Cell Lymphomas.
Journal Title:	Journal of the National Comprehensive Cancer Network
Volume:	20
Issue:	3
ISSN:	1540-1405
Publisher:	Harborside Press
Date Published:	2022-03-01
Start Page:	285
End Page:	308
Language:	English
DOI:	10.6004/jnccn.2022.0015
PUBMED:	35276674
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85126389086&doi=10.6004%2fjnccn.2022.0015&partnerID=40&md5=76649116693b6400e8e3a3bfa0cfb34f
Notes:	Article -- Export Date: 1 April 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/193444